Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Donna J. Mills"'
Publikováno v:
The American Journal of Medicine. 103:491-497
PURPOSE: To study the efficacy and safety of various dosages of metformin as compared with placebo in patients with type II diabetes mellitus. PATIENTS AND METHODS: A 14-week, multicenter, double-blind, dose-response study was conducted. After a 3-we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f5cbc55b3ba3813c3b951ac39be7132
https://doi.org/10.1016/s0002-9343(97)00254-4
https://doi.org/10.1016/s0002-9343(97)00254-4
Autor:
Peter E. Pool, F. Wilford Germino, Michael S. Willett, Juan Lastra, Susan Wallace, Dennis Cryer, Bruce Spinowitz, Jacqueline de Silva, William Benjamin Smith, Henry Punzi, Donna J. Mills
Publikováno v:
Current Therapeutic Research. 54:469-475
To evaluate the cough profile of fosinopril in treated hypertensive patients with active cough associated with angiotensin-converting enzyme (ACE) inhibitors other than fosinopril, a 7-week, prospective, open-label study was undertaken. This consiste
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4a4daac244f3da3c1c471221971ecc3
https://doi.org/10.1016/s0011-393x(05)80665-4
https://doi.org/10.1016/s0011-393x(05)80665-4
Publikováno v:
Diabetes care. 28(3)
OBJECTIVE—Metformin was approved by the Food and Drug Administration in 1995 subject to the conduct of a randomized trial to evaluate the risk of lactic acidosis or other serious adverse events (SAEs) with this agent, under usual care conditions. R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8407c1bded67fb03e0a2baf449a2f24
https://pubmed.ncbi.nlm.nih.gov/15735184
https://pubmed.ncbi.nlm.nih.gov/15735184
Autor:
Nader S. Jallad, Donna J. Mills, Jacqueline de Silva, Michael S. Willett, F. Wilford Germino, Daniel David, Susan M. Weidner
Publikováno v:
American journal of therapeutics. 2(10)
OBJECTIVE: Cough frequency and severity with fosinopril and enalapril were assessed in hypertensive patients with previous angiotensin-converting enzyme inhibitor (ACEI)-associated cough. DESIGN: Prospective, multicenter, randomized, 8-week double-bl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3101a3f91778d315dbb19cd36d730f
https://pubmed.ncbi.nlm.nih.gov/11854791
https://pubmed.ncbi.nlm.nih.gov/11854791